Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain

Cited by (1,021)

Items 301–400 of 1,021

1. Mechanisms of cholinesterase inhibition in senile dementia of the alzheimer type: Clinical, pharmacological, and therapeutic aspects
   Robert E. Becker, Ezio Giacobini · 1988 · Drug Development Research
2. Evidence of an oxidative challenge in the Alzheimer's brain
   Louisa Balázs, Michael Leon · 1994 · Neurochemical Research
3. Individual cells in the nucleus basalis-diagonal band complex have restricted axonal projections to the cerebral cortex in the rat
   Joseph L. Price, Richard Stern · 1983 · Brain Research
4. Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes
   Wong, Tak Pan, Debeir, Thomas, Duff, Karen, Cuello, A. Claudio · 1999 · The Journal of Neuroscience
5. Retrograde changes in cholinergic neurons in the basal forebrain of the rat following cortical damage
   Michael V. Sofroniew, R.C.A. Pearson, Felix P. Eckenstein, A. Claudio Cuello, T.P.S. Powell · 1983 · Brain Research
6. Evolution of Alzheimer's disease-related cytoskeletal changes in the basal nucleus of Meynert
   Irena Sassin, Christian Schultz, Dietmar Rudolf Thal, U. Rüb, Kimihito Arai, Eva Braak, Heiko Braak · 2000 · Acta Neuropathologica
7. Donepezil in Alzheimer’s disease: from conventional trials to pharmacogenetics
   Ramón Cacabelos · 2007 · Neuropsychiatric Disease and Treatment
8. Drugs with anticholinergic properties: a current perspective on use and safety
   Philip Gerretsen, Bruce G. Pollock · 2011 · Expert Opinion on Drug Safety
9. Learning impairment following lesion of the basal nucleus of Meynert in the marmoset: modification by cholinergic drugs.
   R. M. Ridley, T. K. Murray, J. A. Johnson, H. F. Baker · 1986 · Brain Research
10. Cholinergic and peptidergic projections from the medial septum and the nucleus of the diagonal band of broca to dorsal hippocampus, cingulate cortex and olfactory bulb: A combined wheatgerm agglutinin-apohorseradish peroxidase-gold immunohistochemical study
    Marie‐Claude Senut, D. Menétrey, Yvon A. Lamour · 1989 · Neuroscience
11. Apoptosis and Alzheimer's disease
    Christian Behl · 2000 · Journal of Neural Transmission
12. Butyryl‐ and acetyl‐cholinesterase inhibitory activities in essential oils of Salvia species and their constituents
    Sergey U. Savelev, Edward Jonathan Okello, Elaine King Perry · 2004 · Phytotherapy Research
13. The Therapeutic Potential of Rosemary (Rosmarinus officinalis) Diterpenes for Alzheimer’s Disease
    Solomon Habtemariam · 2016 · Evidence-based Complementary and Alternative Medicine
14. Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates
    Vassilis E. Koliatsos, Richard E. Clatterbuck, Haring J. W. Nauta, Beat Knüsel, Louis E. Burton, Franz F. Hefti, William Cary Mobley, Donald L. Price · 1991 · Annals of Neurology
15. The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor.
    Jeffrey H. Kordower, Shelley R. Winn, Y T Liu, Elliott Jay Mufson, John R. Sladek, Joseph P. Hammang, E. Edward Baetge, Df Emerich · 1994 · Proceedings of the National Academy of Sciences
16. Phenserine and ring C hetero‐analogues: Drug candidates for the treatment of Alzheimer's disease
    Nigel H. Greig, Xue‐Feng Pei, Timothy T. Soncrant · 1995 · Medicinal Research Reviews
17. Implants of polymer‐encapsulated human NGF‐secreting cells in the nonhuman primate: Rescue and sprouting of degenerating cholinergic basal forebrain neurons
    Dwaine F. Emerich, Shelley R. Winn, James S. Harper, Joseph P. Hammang, E. Edward Baetge, Jeffrey H. Kordower · 1994 · The Journal of Comparative Neurology
18. Aneurysm of the anterior communicating artery: A review of neuroanatomical and neuropsychological sequelae
    John DeLuca, Bruce J. Diamond · 1995 · Journal of Clinical and Experimental Neuropsychology
19. Cortical neurons express nerve growth factor receptors in advanced age and Alzheimer disease.
    Elliott J. Mufson, Jeffrey H. Kordower · 1992 · Proceedings of the National Academy of Sciences
20. The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease
    Uwe Beffert · 1998 · Brain Research Reviews
21. Trace element imbalances in isolated subcellular fractions of Alzheimer's disease brains
    D. E. Wenstrup, William D. Ehman, William R. Markesbery · 1990 · Brain Research
22. Senile plaques in cortex of aged normal monkeys.
    R. Struble, D. L. Price, L. Cork · 1985 · Brain Research
23. Non-classical actions of cholinesterases: Role in cellular differentiation, tumorigenesis and Alzheimer's disease
    David Henry Small, Samantha Michaelson, Gian Sberna · 1996 · Neurochemistry International
24. Curcumin Improves Amyloid β-Peptide (1-42) Induced Spatial Memory Deficits through BDNF-ERK Signaling Pathway
    Lu Zhang, Yu Fang, Yuming Xu, Yajun Lian, Nanchang Xie, Tianwen Wu, Haifeng Zhang, Limin Sun, Ruifang Zhang, Zhenhua Wang · 2015 · PLoS ONE
25. Down‐regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer's disease
    Sara L. Kirvell, Margaret M. Esiri, Paul T. Francis · 2006 · Journal of Neurochemistry
26. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease.
    E. Mufson, N. Lavine, S. Jaffar, J. Kordower, R. Quirion, H. Saragovi · 1997 · Experimental Neurology
27. The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain
    Anna Gąsiorowska, Małgorzata Wydrych, Patrycja Drapich, Maciej Zadrożny, Marta Steczkowska, Wiktor Niewiadomski, Grażyna Niewiadomska · 2021 · Frontiers in Aging Neuroscience
28. Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade
    Yuki Takada‐Takatori, Toshiaki Kume, Mitsuhiro Sugimoto, Hiroshi Katsuki, Hachiro Sugimoto, Akinori Akaike · 2006 · Neuropharmacology
29. Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease
    Alan M. Palmer, Gordon Keith Wilcock, Margaret M. Esiri, Paul T. Francis, David M. Bowen · 1987 · Brain Research
30. A mitochondrial DNA clone is associated with increased risk for Alzheimer disease.
    Tim P. Hutchin, Gino A. Cortopassi · 1995 · Proceedings of the National Academy of Sciences
31. Cholinergic ventral forebrain grafts into the neocortex improve passive avoidance memory in a rat model of Alzheimer disease.
    A Fine, Stephen B. Dunnett, Anders Björklund, Susan D. Iversen · 1985 · Proceedings of the National Academy of Sciences
32. Characteristics of memory impairment following lesioning of the basal forebrain and medial septal nucleus in rats
    Masaomi Miyamoto, Junko Kato, Shigehiko Narumi, Akinobu Nagaoka · 1987 · Brain Research
33. The p75 Neurotrophin Receptor Promotes Amyloid-β(1-42)-Induced Neuritic Dystrophy<i>In Vitro</i>and<i>In Vivo</i>
    Knowles, Juliet K., Rajadas, Jayakumar, Nguyen, Thuy-Vi V., Yang, Tao, LeMieux, Melburne C., Vander Griend, Lilith, Ishikawa, Chihiro, Massa, Stephen M., Wyss-Coray, Tony, Longo, Frank M. · 2009 · The Journal of Neuroscience
34. Environmental enrichment results in higher levels of nerve growth factor mRNA in the rat visual cortex and hippocampus
    Marita Torasdotter, Madis L. METSIS, Bengt G. Henriksson, Bengt G. Winblad, Abdul Hadi Sallal Mohammed · 1998 · Behavioural Brain Research
35. Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model
    Susan E. Molchan, Rick A. Martínez, James Hill, Herbert J. Weingartner, Karen Thompson, Benedetto Vitiello, Trey Sunderland · 1992 · Brain Research Reviews
36. Memory deficits in Alzheimer's patients: A comprehensive review
    Giovanni Augusto Carlesimo, Marlene Oscar‐Berman · 1992 · Neuropsychology Review
37. Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry.
    Graham G Lennox, James S Lowe, Michael Landon, Eleanor Jane Byrne, R. John Mayer, Richard B. Godwin-Austen · 1989 · Journal of Neurology Neurosurgery & Psychiatry
38. Interleukin 3 as a trophic factor for central cholinergic neurons in vitro and in vivo
    Masahiro Kamegai, Kenji Niijima, Tatsuhide Kunishita, Masatoyo Nishizawa, Matsuo Ogawa, Masasuke Araki, Akira Ueki, Yoshihiro Konishi, Takeshi Tabira · 1990 · Neuron
39. Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain
    Mark H. Tuszynski, Hoi Sang U, Kazunari Yoshida, Fred H. Gage · 1991 · Annals of Neurology
40. Hypothalamic γ-Aminobutyric Acid Neurons Project to the Neocortex
    Steven R. Vincent, Tomas G. M. Hökfelt, Lana R. Skirboll, Jang‐Yen Wu · 1983 · Science
41. Mitochondrial function in brain tissue in primary degenerative dementia
    Neil R. Sims, Janet M. Finegan, John P. Blass, David M. Bowen, D. Neary · 1987 · Brain Research
42. Is ?subcortical dementia? a recognizable clinical entity?
    Richard P Mayeux, Yaakov Stern, Jeffery Rosen, D. Frank Benson · 1983 · Annals of Neurology
43. Extent of Dorsolateral Prefrontal Cortex Plasticity and Its Association With Working Memory in Patients With Alzheimer Disease
    Sanjeev Kumar, Reza Zomorrodi, Zaid Ghazala, Michelle S. Goodman, Daniel M. Blumberger, Amay Cheam, Corinne Eleanor Fischer, Zafiris Jeff Daskalakis, Benoit H. Mulsant, Bruce G. Pollock et al. · 2017 · JAMA Psychiatry
44. An update on the utility and safety of cholinesterase inhibitors for the treatment of Alzheimer’s disease
    Andrea Haake, Kevin T. Nguyen, Lauren G. Friedman, Binu Chakkamparambil, George Thomas Grossberg · 2020 · Expert Opinion on Drug Safety
45. Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease
    Barry Horwitz, C.L. Grady, Nicholas L. Schlageter, Ranjan Duara, С. И. Рапопорт · 1987 · Brain Research
46. The Cholinergic Neurotransmitter System in Human Memory and Dementia: A Review
    Michael D. Kopelman · 1986 · The Quarterly Journal of Experimental Psychology Section A
47. Loss of pedunculopontine neurons in progressive supranuclear palsy
    Richard M. Zweig, Peter John Whitehouse, Manuel Fernando Casanova, Lary C. Walker, William R. Januarykel, Donald L. Price · 1987 · Annals of Neurology
48. The endocannabinoid system as a target for the treatment of neurodegenerative disease
    Emma L. Scotter, Mary E. Abood, Michelle Glass · 2010 · British Journal of Pharmacology
49. Regional cortical dysfunction in Alzheimer's disease as determined by positron emission tomography
    Thomas N. Chase, Norman L. Foster, Paul Fedio, Rodney Brooks, Luigi Mansi, Giovanni Di Chiro · 1984 · Annals of Neurology
50. The Neuroanatomy of Alzheimer's Disease
    R.C.A. Pearson, T.P.S. Powell · 1989 · Reviews in the Neurosciences
51. The cholinergic innervation of the rat fascia dentata: Identification of target structures on granule cells by combining choline acetyltransferase immunocytochemistry and Golgi impregnation
    Michael Frotscher, Csaba Léránth · 1986 · The Journal of Comparative Neurology
52. Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease
    Magdolna Pákáski, Janos L. Kalman · 2008 · Neurochemistry International
53. The roles of hnRNP A2 / B1 in RNA biology and disease
    Yu Liu, Songlin Shi · 2020 · Wiley Interdisciplinary Reviews - RNA
54. Transgenic mouse models of Alzheimer's disease
    Christopher Janus, David A. Westaway · 2001 · Physiology & Behavior
55. Reinnervation of the hippocampal perforant pathway zone in Alzheimer's disease
    Hyman, B. T., Kromer, L. J., van Hoesen, G. W. · 1987 · Annals of Neurology
56. Serum BDNF, TNF-α and IL-1β levels in dementia patients
    Chie Yasutake, Kenji Kuroda, Toshio Yanagawa, Takehiko Okamura, Hiroshi Yoneda · 2006 · European Archives of Psychiatry and Clinical Neuroscience
57. Galantamine-induced Amyloid-β Clearance Mediated via Stimulation of Microglial Nicotinic Acetylcholine Receptors
    Takata, Kazuyuki, Kitamura, Yoshihisa, Saeki, Mana, Terada, Maki, Kagitani, Sachiko, Kitamura, Risa, Fujikawa, Yasuhiro, Maelicke, Alfred, Tomimoto, Hidekazu, Taniguchi, Takashi et al. · 2010 · Journal of Biological Chemistry
58. The grey mouse lemur: A non-human primate model for ageing studies
    Solène Languille, Stéphane Blanc, Olivier J. Blin, Cindy I. Canale, Alexandre Dal‐Pan, Gina Devau, Marc Dhénain, Olène Dorieux, Jacques Epelbaum, Doris Gomez et al. · 2011 · Ageing Research Reviews
59. Exploring the Pathogenesis of Alzheimer Disease in Basal Forebrain Cholinergic Neurons: Converging Insights From Alternative Hypotheses
    Xu‐Qiao Chen, William Cary Mobley · 2019 · Frontiers in Neuroscience
60. Effect of rivastigmine on scopolamine-induced memory impairment in rats
    Corina Bejar, R.-H. Wang, Marta Weinstock · 1999 · European Journal of Pharmacology
61. Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts
    Pantéleimon Giannakopoulos, Patrick R. Hof, Jean‐Pierre Michel, José Guimón, Constantin Bouras · 1997 · Brain Research Reviews
62. Increases in hippocampal and frontal cortical acetylcholine release associated with presentation of sensory stimuli
    Fiona M. Inglis, H. Christian Fibiger · 1995 · Neuroscience
63. Cholinergic enzymes in neocortex, hippocampus and basal forebrain of non-neurological and senile dementia of alzheimer-type patients
    H. Henke, W. Lang · 1983 · Brain Research
64. Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia
    Hideo Tohgi, Takashi Abe, M Kimura, Mika Saheki, Satoshi Takahashi · 1996 · Journal of Neural Transmission
65. Nicotine as a cognitive enhancer
    David M. Warburton · 1992 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
66. Current approaches in the treatment of Alzheimer's disease
    Reena S. Shah, Hyoung‐gon Lee, Xiongwei Zhu, George L. Perry, Mark A. Smith, Rudy J. Castellani · 2008 · Biomedicine & Pharmacotherapy
67. Dementia of the Alzheimer Type
    Jessica J. Jalbert, Lori A. Daiello, Kate L. Lapane · 2008 · Epidemiologic Reviews
68. Pharmacological evidence of cholinergic involvement in adult hippocampal neurogenesis in rats
    S. Kotani, T. Yamauchi, T. Teramoto, H. OGURA · 2006 · Neuroscience
69. Near-total loss of ‘learning’ and ‘memory’ as a result of combined cholinergic and serotonergic blockade in the rat
    C.H. Vanderwolf · 1987 · Behavioural Brain Research
70. Neuropsychological Contributions to the Early Identification of Alzheimer’s Disease
    Bondi, Mark W., Jak, Amy J., Delano-Wood, Lisa, Jacobson, Mark W., Delis, Dean C., Salmon, David P. · 2008 · Neuropsychology Review
71. Ectopic Cell Cycle Events Link Human Alzheimer's Disease and Amyloid Precursor Protein Transgenic Mouse Models
    Yan Yang, Nicholas H. Varvel, Bruce T. Lamb, Karl Herrup · 2006 · Journal of Neuroscience
72. Hippocampal plasticity during the progression of Alzheimer’s disease
    Elliott Jay Mufson, Laura J. Mahady, D. Waters, Scott Counts, Sylvia E. Perez, Steven Trent DeKosky, Stephen D. Ginsberg, Miloš D. Ikonomović, Stephen W. Scheff, Lester I. Binder · 2015 · Neuroscience
73. Potential use of nerve growth factor to treat Alzheimer's disease
    Creighton H. Phelps, Fred H. Gage, John H. Growdon, Franz F. Hefti, Robert E. Harbaugh, Michael V. Johnston, Zaven S. Khachaturian, William Cary Mobley, Donald L. Price, Murray A. Raskind et al. · 1989 · Neurobiology of Aging
74. Acetyl- and butyrylcholinesterase inhibitory activities of sterols and phlorotannins from Ecklonia stolonifera
    Na Young Yoon, Hae Young Chung, Hyeung Rak Kim, Jae Sue Choi · 2008 · Fisheries Science
75. Cholinergic Excitation of Septohippocampal GABA But Not Cholinergic Neurons: Implications for Learning and Memory
    Min Wu, Marya Shanabrough, Csaba Léránth, Meenakshi Alreja · 2000 · Journal of Neuroscience
76. Mouse nerve growth factor prevents degeneration of axotomized basal forebrain cholinergic neurons in the monkey
    VE Koliatsos, Haring J. W. Nauta, R. E. Clatterbuck, David M. Holtzman, William Cary Mobley, DL Price · 1990 · Journal of Neuroscience
77. Behavioural and neurochemical effects of chronic intraventricular injections of nerve growth factor in adult rats with fimbria lesions
    Bruno E. Will, Franz F. Hefti · 1985 · Behavioural Brain Research
78. Zinc and Alzheimer's disease: is there a direct link?
    Math P. Cuajungco, Gordon J. Lees · 1997 · Brain Research Reviews
79. The cholinergic system, circadian rhythmicity, and time memory
    Roelof A. Hut, Eddy A. van der Zee · 2010 · Behavioural Brain Research
80. Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease.
    Pietro Tiraboschi, L. Hansen, M. Alford, A. Merdes, E. Masliah, L. Thal, J. Corey-Bloom · 2002 · Archives of General Psychiatry
81. Somatostatin and dementia in Parkinson's disease
    Jacques Epelbaum, Merle Ruberg, Emmanuel Moyse · 1983 · Brain Research
82. Mitochondrial involvement in Alzheimer’s disease
    Eduardo Bonilla, Kurenai Tanji, Michio Hirano, Tuan Vu, Salvatore DiMauro, Eric A. Schon · 1999 · Biochimica et Biophysica Acta (BBA) - Bioenergetics
83. Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease
    Feng Zheng, Yang Sil Chang, Yong Cheng, B W Zhang, Zhi‐wei Qu, Chuan Qin, Juntian Zhang · 2004 · Journal of Pineal Research
84. The role of cytoskeletal and cytocontractile elements in pathologic processes.
    Elisabeth Rungger‐Brändle, Giulio Gabbiani · 1983 · PubMed Central
85. Subcortical dementia revisited: Similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA)
    Thomas H. Bak, Lewis Crawford, Vanessa Hearn, Pavagada Sivasankara Mathuranath, J. R. Hodges · 2005 · Neurocase
86. Long-Term Neuropathological and Neurochemical Effects of Nucleus Basalis Lesions in the Rat
    Gary W. Arendash, William J. Millard, Adrian J. Dunn, Edwin M. Meyer · 1987 · Science
87. Environmental influence on behaviour and nerve growth factor in the brain
    Abdul Kabir Mohammed, Bengt G. Winblad, Ted Ebendal, Lena Lärkfors · 1990 · Brain Research
88. Anticholinergics: theoretical and clinical overview
    Nishtala, Prasad S., Salahudeen, Mohammed Saji, Hilmer, Sarah N. · 2016 · Expert Opinion on Drug Safety
89. Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine‐induced seizure activity
    Frank P. Bymaster, Petra A. Carter, Masahisa Yamada, Jesús Gomeza, Jürgen Wess, Susan E. Hamilton, Neil M. Nathanson, David L. McKinzie, Christian C. Felder · 2003 · European Journal of Neuroscience
90. Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer’s disease: A role for cholinergic transmission
    Jonathan P. Wisor, Dale M. Edgar, Jerome Albert Yesavage, Heather S. Ryan, C.M. McCormick, Nicolae Lapustea, Greer M. Murphy · 2005 · Neuroscience
91. No global neocortical nerve cell loss in brains from patients with senile dementia of Alzheimer's type.
    Lisbeth Regeur, G. B. Jensen, H. Pakkenberg, S. M. Evans, Bente Pakkenberg · 1994 · Neurobiology of Aging
92. Apolipoprotein E and cholesterol in aging and disease in the brain
    de Chaves, Elena Posse, Narayanaswami, Vasanthy, Christoffersen, Christina, Nielsen, Lars Bo · 2008 · Future Lipidology
93. Angiotensins in Alzheimer's disease - friend or foe?
    Pat Kehoe, S. Miners, S. Love · 2009 · Trends in Neurosciences
94. Acetylcholine and memory: A long, complex and chaotic but still living relationship
    Jacques Micheau, Aline Marighetto · 2010 · Behavioural Brain Research
95. Cell type-specific long-range connections of basal forebrain circuit
    Johnny Phong Hoang Do, Min Xu, Seung‐Hee Lee, Wei-Cheng Chang, Siyu Zhang, Shinjae Chung, Tyler J Yung, Jiang Lan Fan, Kazunari Miyamichi, Liqun Luo et al. · 2016 · eLife
96. Biology of Mitochondria in Neurodegenerative Diseases
    Lee J. Martin · 2012 · Progress in molecular biology and translational science
97. Dissociations Among Structural-Perceptual, Lexical-Semantic, and Event-Fact Memory Systems in Alzheimer, Amnesic, and Normal Subjects
    John D. E. Gabrieli, Margaret M. Keane, Ben Z. Stanger, Margaret Kjelgaard, Suzanne Corkin, John H. Growdon · 1994 · Cortex
98. Neuronal responses related to the novelty and familiarity of visual stimuli in the substantia innominata, diagonal band of Broca and periventricular region of the primate basal forebrain
    Fraser A.W. Wilson, Edmund T. Rolls · 1990 · Experimental Brain Research
99. Update on the Pharmacological Treatment of Alzheimers Disease
    Fadi Massoud, Serge G. Gauthier · 2010 · Current Neuropharmacology
100. Lethal impairment of cholinergic neurotransmission in hemicholinium-3-sensitive choline transporter knockout mice
     Shawn M. Ferguson, Mihaela H. Bazalakova, Valentina L. Savchenko, Juan Carlos Tapia, Jane Wright, Randy Blakely · 2004 · Proceedings of the National Academy of Sciences